1. Home
  2. BODI vs QTTB Comparison

BODI vs QTTB Comparison

Compare BODI & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

HOLD

Current Price

$10.45

Market Cap

82.8M

Sector

Industrials

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$5.79

Market Cap

92.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BODI
QTTB
Founded
1998
2015
Country
United States
United States
Employees
270
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.8M
92.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BODI
QTTB
Price
$10.45
$5.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$15.00
$13.00
AVG Volume (30 Days)
84.7K
238.6K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.78
EPS
N/A
N/A
Revenue
N/A
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$20.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.38
$1.40
52 Week High
$16.87
$8.05

Technical Indicators

Market Signals
Indicator
BODI
QTTB
Relative Strength Index (RSI) 37.31 50.87
Support Level $9.55 $5.51
Resistance Level $10.92 $6.37
Average True Range (ATR) 1.48 0.52
MACD -0.56 0.06
Stochastic Oscillator 6.73 53.70

Price Performance

Historical Comparison
BODI
QTTB

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: